Plum A+ Family of Infusers 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Hospira 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-02-05
  • 사례 출판 날짜
    2013-02-05
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: hospira plum a+ family of infusers (fluid shield diaphragm out of specification) the medicines and healthcare products regulatory agency (mhra), united kingdom posted a medical device safety alert concerning plum a+ family of infusers manufactured by hospira uk limited. the affected list numbers are: 11005 (plum a+ hyperbaric infusion system) 11971, 12391 (plum a+ single channel infusion system) 12348, 12618 (plum a+3 infusion pump system) 20678 (plum a+3 infusion pump with hospira mednet software) 20792 (plum a+ infusion pump with hospira mednet software) according to the manufacturer, there is a potential for the plum a+ fluid shield diaphragm to be out of specification and cause n250“door open while pumping” or n100“unrecognisable cassette” alarms. these alarms invoke audible and visual warnings to the user, which may occur during setup, infusion or performance verification testing and will cause the device set up to be interrupted or the infusion to stop. hospira explained that if these alarms occur whilst the clinician is setting up the pump or an infusion is in progress, a delay or interruption in therapy may result. the severity in the delay or interruption in therapy is dependent upon the underlying condition of the patient and the treatment being prescribed. a delay or interruption in therapy has a worst case potential to result in significant injury or death. to correct this issue, in september 2012, hospira implemented a screening process to identify out of specification diaphragms at their manufacturing and service centres. plum a+ devices shipped since that point successfully went through this screening process and have diaphragms that are within specification. additionally hospira is working with the supplier to ensure all future parts are manufactured within specification. hospira will be contacting the customers to arrange for screening and if necessary replacement of any out of specification diaphragms. meanwhile, in order to prevent the occurrence of n250 and n100 alarms, hospira advised the affected customers to take the following steps, as detailed in the plum system operating manual (430-95597-008 b, 2012-11), regarding the insertion of the cassette. in addition, if the unrecognisable cassette alarm (n100) occurs during the cassette loading process prior to infusion, hospira recommended the affected customers to remove the cassette and attempt to reload the cassette again. if this action does not resolve the alarm issue, it is recommended that an alternative pump be used to minimise delay in patient treatment. if either the n250 or n100 alarm occurs during the infusion, users should safely remove the set from the pump (clamp the line before removal, as detailed in the system operating manual) and continue the infusion with another plum a+ pump. in either case, users should isolate the affected pump so that it can be tested away from the patient environment with new tubing set. if the problem continues, the pump should be removed from active service. this case should then be reported to the local hospira office. for details, please visit the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/ fieldsafetynotices/con226996 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 05 february 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Hospira Plum A+ Family of Infusers
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH